Sales and Marketing Best Practices: Deal Elements

ABOUT US

RESEARCH & CONSULTING

BENCHMARKING REPORTS

BEST PRACTICE DATABASE

RESEARCH & ADVISORY SERVICES

BEST PRACTICES EXCELLENCE SERVICES

Advanced Search

Wizards and Analytics Search

Simple Search

By Subject Area

Sales and Marketing > Strategic Alliances > Managing Deal-Making Process > Deal Elements

Deal Elements Research

Pharma-Biotech Alliance Management Success: Deal Evaluation and Negotiation

Non-members: Click here to sign-up for a complimentary tour of "Pharma-Biotech Alliance Management Success: Deal Evaluation and Negotiation" Study Overview To prosper, pharmaceutical and biotechnology companies must forge strong development and marketing alliances... (ID 4770)
Companies Profiled: Atrix, AtheroGenics, Bristol-Myers Squibb, CV Therapeutics, more ...
Price: $1562.00

Pharma & Biotech Co-Promotion Alliance and Relationship Management

Non-members: Click here to sign-up for a complimentary tour of "Pharma & Biotech Co-Promotion Alliance and Relationship Management" Study Overview The success of any co-development deal or co-promotion deal hinges on stellar alliance execution and careful relationship management... (ID 4769)
Companies Profiled: Atrix, AtheroGenics, Bristol-Myers Squibb, CV Therapeutics, more ...
Price: $1184.00

Managing The Pharmaceutical In-Licensing Process

Study Overview Research indicates that support staff and organized processes are often insufficient to manage the array of activities required to effectively step through the in-licensing process... (ID 4674)
Companies Profiled: AstraZeneca, Sanofi-aventis, Fujisawa, Boehringer-Ingelheim, more ...
Price: $834.95

In-Licensing Process: Steps to Accelerate Assessment and Agreement

This 22-page document examines key processes that drive high-performing in-licensing operations... (ID 4499)
Companies Profiled: AstraZeneca, Sanofi-aventis, Roche, Wyeth, more ...
Price: $574.95

In-Licensing Organization Structure

This 19-page document examines key elements that determine the structure of high-performing in-licensing operations... (ID 4498)
Companies Profiled: AstraZeneca, Sanofi-aventis, Bristol-Myers Squibb, GlaxoSmithKline , more ...
Price: $574.95

All contents copyright � 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.